Insider Transactions Reported by 16 Insiders of BIOVIE INC.

Symbol
BIVI, BIVIW on Nasdaq
Location
Carson City, NV

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

BIOVIE INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jonathan M. Adams EVP Liver Cirrhosis Programs $82,185 02 Feb 2022
Penelope Markham EVP Liver Cirrhosis R&D $80,851 16 Feb 2023
Steve Gorlin Director $78,345 09 Nov 2023
Cuong Do V President & CEO, Director $71,342 05 Jan 2026
Christopher Reading EVP Neuroscience R&D $62,780 16 Feb 2023
Clarence N. Ahlem EVP Neuroscience Product Dev. $62,780 16 Feb 2023
Richard J. Berman Director $19,265 20 Nov 2024
Amy Suzon Chappell Director 05 Jan 2026
Sigmund Rogich Director 05 Jan 2026
Kameel D. Farag Director 05 Jan 2026
Michael Edward Sherman Director 05 Jan 2026
Terren S. Peizer Director, 10%+ Owner 23 Nov 2022
James Paul Lang Director 05 Jan 2026
Joseph M. Palumbo MD Chief Medical Officer 05 Jan 2026
Joanne Wendy Kim Chief Financial Officer 05 Jan 2026
Robert J. Hariri Director 20 Nov 2024

Recent Insider Transactions by Companies or Individuals for BIOVIE INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Joseph M. Palumbo MD BIVI Stock Option (right to buy) Award 132,000 132,000 05 Jan 2026 Direct
Joanne Wendy Kim BIVI Stock Option (right to buy) Award 110,100 110,100 05 Jan 2026 Direct
Sigmund Rogich BIVI Stock Option (right to buy) Award 211,100 141,100 05 Jan 2026 Direct
Cuong V Do BIVI Stock Option (right to buy) Award 665,300 665,300 05 Jan 2026 See Footnote
Michael Edward Sherman BIVI Stock Option (right to buy) Award 421,100 341,100 05 Jan 2026 Direct
Kameel D. Farag BIVI Stock Option (right to buy) Award 57,500 57,500 05 Jan 2026 Direct
Amy Suzon Chappell BIVI Stock Option (right to buy) Award 57,500 57,500 05 Jan 2026 Direct
James Paul Lang BIVI Stock Option (right to buy) Award 420,500 330,500 05 Jan 2026 Direct
Cuong V Do BIVI Common Stock Purchase 100.2% 5,000 9,992 07 Aug 2025 See Footnote
Cuong V Do BIVI Warrants (right to buy) Purchase 10000% 5,000 5,050 07 Aug 2025 See Footnote
* An asterisk sign (*) next to the price indicates that the price is likely invalid.